Edwin Naylor
Vorstandsvorsitzender bei EnMed MicroAnalytics, Inc.
Profil
Edwin Naylor is the founder of EnMed MicroAnalytics, Inc. He currently works as a Director at Parabase Genomics, Inc. He previously worked as a Director at DiaVacs, Inc.
Aktive Positionen von Edwin Naylor
| Unternehmen | Position | Beginn |
|---|---|---|
Parabase Genomics, Inc.
 Parabase Genomics, Inc. Medical/Nursing ServicesHealth Services Parabase Genomics, Inc. offers neonatal and pediatric diagnostics. The firm offers neonatal care through the development of early diagnostics for actionable inherited disorders. The company was founded by Gabor Bethlendy and Andy Bhattacharjee is headquartered in Boston, MA. | Direktor/Vorstandsmitglied | - |
| EnMed MicroAnalytics, Inc. | Vorstandsvorsitzender | 01.01.2017 |
Ehemalige bekannte Positionen von Edwin Naylor
| Unternehmen | Position | Ende |
|---|---|---|
DiaVacs, Inc.
 DiaVacs, Inc. BiotechnologyHealth Technology DiaVacs, Inc. develops and commercializes cell-based therapies for the treatment of type 1 diabetes. The company is based in La Jolla, CA. The company was founded by Dietrich A. Stephan, Nick Giannoukakis, and David L. Finegold. Alan J. Lewis has been the CEO of the company since 2015. | Direktor/Vorstandsmitglied | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Parabase Genomics, Inc.
Parabase Genomics, Inc. Medical/Nursing ServicesHealth Services Parabase Genomics, Inc. offers neonatal and pediatric diagnostics. The firm offers neonatal care through the development of early diagnostics for actionable inherited disorders. The company was founded by Gabor Bethlendy and Andy Bhattacharjee is headquartered in Boston, MA. | Health Services |
DiaVacs, Inc.
DiaVacs, Inc. BiotechnologyHealth Technology DiaVacs, Inc. develops and commercializes cell-based therapies for the treatment of type 1 diabetes. The company is based in La Jolla, CA. The company was founded by Dietrich A. Stephan, Nick Giannoukakis, and David L. Finegold. Alan J. Lewis has been the CEO of the company since 2015. | Health Technology |
| EnMed MicroAnalytics, Inc. |
